Drugs / Artefill
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02009462 | Dec 2013 → Nov 2019 | AIDS dysmorphic syndrome | Gerald Pierone, Jr. M.D. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01559922 | Feb 2012 → Apr 2013 | skin atrophy | Suneva Medical, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Artefill | “Use of Artefill® for Moderate to Severe Atrophic Acne Scar Correction” NCT01559922 ↗ |
| Modality | Other / unclassified | “Artefill is an injectable facial filler device” NCT02009462 ↗ |